financetom
Business
financetom
/
Business
/
Trump Media Closes Cronos Purchase Agreement With Crypto.com
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Trump Media Closes Cronos Purchase Agreement With Crypto.com
Sep 5, 2025 6:12 AM

08:57 AM EDT, 09/05/2025 (MT Newswires) -- Trump Media and Technology Group ( DJT ) said Friday it closed a purchase agreement with Crypto.com to buy 684.4 million Cronos tokens.

Under the deal, the company purchased CRO at about $0.153 per token in a transaction equally split between cash and stock, Trump Media ( DJT ) said.

Both the exchanged CRO tokens and Trump Media ( DJT ) shares will be subject to a lockup period, the company added.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Innergex First-Quarter Loss Widens More Than Expected
Innergex First-Quarter Loss Widens More Than Expected
May 8, 2024
04:00 PM EDT, 05/08/2024 (MT Newswires) -- Innergex Renewable Energy ( INGXF ) said Wednesday reported a wider than expected first-quarter loss. The renewable-power company posted a first-quarter loss attributable to owners of C$37.66 million, or C$0.21 per share, in the period, compared to a loss of $12.03 million, or $0.08, a year earlier and wider than the consensus estimate...
--Duolingo Guides For Q2 Revenue of $175-$177.5 Million, vs CIQ Analyst Consensus of $177 Million; Full Year 2024 Revenue Seen at $726.5-$735.5 Million, vs Consensus of $729 Million
--Duolingo Guides For Q2 Revenue of $175-$177.5 Million, vs CIQ Analyst Consensus of $177 Million; Full Year 2024 Revenue Seen at $726.5-$735.5 Million, vs Consensus of $729 Million
May 8, 2024
04:03 PM EDT, 05/08/2024 (MT Newswires) -- Price: 234.25, Change: -10.39, Percent Change: -4.25 ...
Cel-Sci Gets US FDA Clearance to Proceed With Confirmatory Study for Cancer Drug Multikine
Cel-Sci Gets US FDA Clearance to Proceed With Confirmatory Study for Cancer Drug Multikine
May 8, 2024
04:02 PM EDT, 05/08/2024 (MT Newswires) -- Cel-Sci ( CVM ) said Wednesday the US Food and Drug Administration indicated in a recent meeting that the company can move forward with a confirmatory registration study of its investigational cancer treatment Multikine. The confirmatory trial needs to enroll 212 subjects and will be conducted in patients with newly diagnosed advanced primary...
Arm's quarterly revenue forecast beats Street; annual rev guidance misses
Arm's quarterly revenue forecast beats Street; annual rev guidance misses
May 8, 2024
(Reuters) -Chip designer Arm Holdings gave a fiscal first-quarter revenue forecast on Wednesday that beat Wall Street's expectations, but its full-year forecast was below expectations. Shares of Arm fell about 4% in extended trading after the report. For the current fiscal first quarter, Arm forecast revenue in a range between $875 million and $925 million, with a midpoint of $900...
Copyright 2023-2026 - www.financetom.com All Rights Reserved